US Stock MarketDetailed Quotes

ATYR aTyr Pharma

Watchlist
  • 1.880
  • 0.0000.00%
Trading Aug 6 09:54 ET
129.74MMarket Cap-2136P/E (TTM)

aTyr Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
235K
-96.60%353K
0
353K
0
0
10.39M
10.39M
0
0
Operating revenue
--235K
-96.60%353K
--0
--353K
--0
--0
--10.39M
--10.39M
--0
--0
Cost of revenue
Gross profit
Operating expense
31.94%16.87M
-2.67%55.27M
-12.96%15.96M
-3.88%12.97M
7.74%13.56M
3.30%12.79M
66.96%56.79M
112.22%18.34M
74.59%13.49M
20.48%12.58M
Selling and administrative expenses
2.90%3.51M
-7.17%12.98M
-6.48%3.2M
-26.92%2.65M
7.80%3.72M
-2.13%3.41M
30.05%13.98M
27.60%3.43M
39.96%3.63M
23.62%3.45M
-General and administrative expense
2.90%3.51M
-7.17%12.98M
-6.48%3.2M
-26.92%2.65M
7.80%3.72M
-2.13%3.41M
30.05%13.98M
27.60%3.43M
39.96%3.63M
23.62%3.45M
Research and development costs
42.49%13.36M
-1.20%42.29M
-14.45%12.76M
4.58%10.32M
7.72%9.84M
5.43%9.38M
84.01%42.81M
150.38%14.91M
92.04%9.87M
19.33%9.14M
Operating profit
-30.10%-16.64M
-18.35%-54.92M
-100.74%-15.96M
6.50%-12.62M
-7.74%-13.56M
-3.30%-12.79M
-36.42%-46.4M
7.99%-7.95M
-74.59%-13.49M
-20.48%-12.58M
Net non-operating interest income expense
Other net income (expense)
37.60%1.15M
326.20%4.52M
180.56%1.2M
415.38%1.27M
646.01%1.22M
272.77%835K
345.80%1.06M
440.51%427K
318.64%247K
207.55%163K
Other non- operating income (expenses)
37.60%1.15M
326.20%4.52M
180.56%1.2M
415.38%1.27M
646.01%1.22M
272.77%835K
345.80%1.06M
440.51%427K
318.64%247K
207.55%163K
Income before tax
-29.58%-15.49M
-11.15%-50.4M
-96.21%-14.76M
14.37%-11.34M
0.64%-12.34M
1.66%-11.95M
-34.24%-45.34M
12.12%-7.52M
-72.71%-13.25M
-19.52%-12.42M
Income tax
Net income
-29.58%-15.49M
-11.15%-50.4M
-96.21%-14.76M
14.37%-11.34M
0.64%-12.34M
1.66%-11.95M
-34.24%-45.34M
12.12%-7.52M
-72.71%-13.25M
-19.52%-12.42M
Net income continuous Operations
-29.58%-15.49M
-11.15%-50.4M
-96.21%-14.76M
14.37%-11.34M
0.64%-12.34M
1.66%-11.95M
-34.24%-45.34M
12.12%-7.52M
-72.71%-13.25M
-19.52%-12.42M
Minority interest income
500.00%4K
-60.00%-8K
50.00%-1K
-100.00%-2K
-300.00%-4K
0.00%-1K
44.44%-5K
0.00%-2K
50.00%-1K
0.00%-1K
Net income attributable to the parent company
-29.62%-15.49M
-11.14%-50.39M
-96.25%-14.76M
14.38%-11.34M
0.66%-12.34M
1.66%-11.95M
-34.26%-45.34M
12.13%-7.52M
-72.74%-13.24M
-19.53%-12.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-29.62%-15.49M
-11.14%-50.39M
-96.25%-14.76M
14.38%-11.34M
0.66%-12.34M
1.66%-11.95M
-34.26%-45.34M
12.13%-7.52M
-72.74%-13.24M
-19.53%-12.42M
Basic earnings per share
20.69%-0.23
41.25%-0.94
3.85%-0.25
56.52%-0.2
50.00%-0.22
34.09%-0.29
9.60%-1.6
16.13%-0.26
-9.52%-0.46
31.25%-0.44
Diluted earnings per share
20.69%-0.23
41.25%-0.94
3.85%-0.25
56.52%-0.2
50.00%-0.22
34.09%-0.29
9.60%-1.6
16.13%-0.26
-9.52%-0.46
31.25%-0.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 235K-96.60%353K0353K0010.39M10.39M00
Operating revenue --235K-96.60%353K--0--353K--0--0--10.39M--10.39M--0--0
Cost of revenue
Gross profit
Operating expense 31.94%16.87M-2.67%55.27M-12.96%15.96M-3.88%12.97M7.74%13.56M3.30%12.79M66.96%56.79M112.22%18.34M74.59%13.49M20.48%12.58M
Selling and administrative expenses 2.90%3.51M-7.17%12.98M-6.48%3.2M-26.92%2.65M7.80%3.72M-2.13%3.41M30.05%13.98M27.60%3.43M39.96%3.63M23.62%3.45M
-General and administrative expense 2.90%3.51M-7.17%12.98M-6.48%3.2M-26.92%2.65M7.80%3.72M-2.13%3.41M30.05%13.98M27.60%3.43M39.96%3.63M23.62%3.45M
Research and development costs 42.49%13.36M-1.20%42.29M-14.45%12.76M4.58%10.32M7.72%9.84M5.43%9.38M84.01%42.81M150.38%14.91M92.04%9.87M19.33%9.14M
Operating profit -30.10%-16.64M-18.35%-54.92M-100.74%-15.96M6.50%-12.62M-7.74%-13.56M-3.30%-12.79M-36.42%-46.4M7.99%-7.95M-74.59%-13.49M-20.48%-12.58M
Net non-operating interest income expense
Other net income (expense) 37.60%1.15M326.20%4.52M180.56%1.2M415.38%1.27M646.01%1.22M272.77%835K345.80%1.06M440.51%427K318.64%247K207.55%163K
Other non- operating income (expenses) 37.60%1.15M326.20%4.52M180.56%1.2M415.38%1.27M646.01%1.22M272.77%835K345.80%1.06M440.51%427K318.64%247K207.55%163K
Income before tax -29.58%-15.49M-11.15%-50.4M-96.21%-14.76M14.37%-11.34M0.64%-12.34M1.66%-11.95M-34.24%-45.34M12.12%-7.52M-72.71%-13.25M-19.52%-12.42M
Income tax
Net income -29.58%-15.49M-11.15%-50.4M-96.21%-14.76M14.37%-11.34M0.64%-12.34M1.66%-11.95M-34.24%-45.34M12.12%-7.52M-72.71%-13.25M-19.52%-12.42M
Net income continuous Operations -29.58%-15.49M-11.15%-50.4M-96.21%-14.76M14.37%-11.34M0.64%-12.34M1.66%-11.95M-34.24%-45.34M12.12%-7.52M-72.71%-13.25M-19.52%-12.42M
Minority interest income 500.00%4K-60.00%-8K50.00%-1K-100.00%-2K-300.00%-4K0.00%-1K44.44%-5K0.00%-2K50.00%-1K0.00%-1K
Net income attributable to the parent company -29.62%-15.49M-11.14%-50.39M-96.25%-14.76M14.38%-11.34M0.66%-12.34M1.66%-11.95M-34.26%-45.34M12.13%-7.52M-72.74%-13.24M-19.53%-12.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -29.62%-15.49M-11.14%-50.39M-96.25%-14.76M14.38%-11.34M0.66%-12.34M1.66%-11.95M-34.26%-45.34M12.13%-7.52M-72.74%-13.24M-19.53%-12.42M
Basic earnings per share 20.69%-0.2341.25%-0.943.85%-0.2556.52%-0.250.00%-0.2234.09%-0.299.60%-1.616.13%-0.26-9.52%-0.4631.25%-0.44
Diluted earnings per share 20.69%-0.2341.25%-0.943.85%-0.2556.52%-0.250.00%-0.2234.09%-0.299.60%-1.616.13%-0.26-9.52%-0.4631.25%-0.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg